- Home
- CELC vs NECB Comparison
CELC vs NECB Comparison
Compare CELC & NECB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- NECB
- Stock Information
- Founded
- CELC 2011
- NECB 1934
- Country
- CELC United States
- NECB United States
- Employees
- CELC N/A
- NECB N/A
- Industry
- CELC Medical Specialities
- NECB Savings Institutions
- Sector
- CELC Health Care
- NECB Finance
- Exchange
- CELC Nasdaq
- NECB Nasdaq
- Market Cap
- CELC 327.3M
- NECB 296.8M
- IPO Year
- CELC 2017
- NECB N/A
- Fundamental
- Price
- CELC $11.62
- NECB $22.33
- Analyst Decision
- CELC Strong Buy
- NECB
- Analyst Count
- CELC 5
- NECB 0
- Target Price
- CELC $30.80
- NECB N/A
- AVG Volume (30 Days)
- CELC 148.5K
- NECB 27.8K
- Earning Date
- CELC 05-14-2025
- NECB 07-21-2025
- Dividend Yield
- CELC N/A
- NECB 3.34%
- EPS Growth
- CELC N/A
- NECB 0.72
- EPS
- CELC N/A
- NECB 3.44
- Revenue
- CELC N/A
- NECB $104,392,000.00
- Revenue This Year
- CELC N/A
- NECB $2.80
- Revenue Next Year
- CELC N/A
- NECB $8.34
- P/E Ratio
- CELC N/A
- NECB $6.52
- Revenue Growth
- CELC N/A
- NECB 2.77
- 52 Week Low
- CELC $7.58
- NECB $16.63
- 52 Week High
- CELC $19.77
- NECB $31.72
- Technical
- Relative Strength Index (RSI)
- CELC 64.24
- NECB 40.79
- Support Level
- CELC $10.50
- NECB $22.55
- Resistance Level
- CELC $10.88
- NECB $23.62
- Average True Range (ATR)
- CELC 0.62
- NECB 0.73
- MACD
- CELC 0.05
- NECB -0.15
- Stochastic Oscillator
- CELC 90.17
- NECB 8.49
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About NECB NorthEast Community Bancorp Inc.
NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.